Consonance Capital Management as of Dec. 31, 2018
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 24 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pacira Pharmaceuticals (PCRX) | 11.6 | $157M | 3.7M | 43.02 | |
| Exelixis (EXEL) | 9.6 | $131M | 6.6M | 19.67 | |
| Amarin Corporation (AMRN) | 9.5 | $129M | 9.5M | 13.61 | |
| Vanda Pharmaceuticals (VNDA) | 8.9 | $122M | 4.7M | 26.13 | |
| United Therapeutics Corporation (UTHR) | 8.8 | $120M | 1.1M | 108.90 | |
| Retrophin | 6.7 | $91M | 4.0M | 22.63 | |
| Corcept Therapeutics Incorporated (CORT) | 6.1 | $83M | 6.2M | 13.36 | |
| Vericel (VCEL) | 5.4 | $73M | 4.2M | 17.40 | |
| Myriad Genetics (MYGN) | 5.1 | $69M | 2.4M | 29.07 | |
| Urogen Pharma (URGN) | 4.8 | $65M | 1.5M | 43.06 | |
| Luminex Corporation | 4.1 | $56M | 2.4M | 23.11 | |
| Uniqure Nv (QURE) | 4.0 | $55M | 1.9M | 28.82 | |
| Karyopharm Therapeutics (KPTI) | 3.3 | $45M | 4.8M | 9.37 | |
| Oxford Immunotec Global | 2.4 | $33M | 2.6M | 12.78 | |
| Spectrum Pharmaceuticals | 1.9 | $26M | 3.0M | 8.75 | |
| Savara (SVRA) | 1.7 | $23M | 3.1M | 7.57 | |
| Pacific Biosciences of California (PACB) | 1.3 | $18M | 2.5M | 7.40 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.3 | $18M | 9.4M | 1.92 | |
| D Stemline Therapeutics | 0.8 | $11M | 1.2M | 9.50 | |
| Adma Biologics (ADMA) | 0.8 | $11M | 4.6M | 2.39 | |
| Sesen Bio | 0.8 | $11M | 7.5M | 1.42 | |
| Radius Health Inc note 3.000% 9/0 | 0.5 | $6.9M | 9.0M | 0.77 | |
| Biosante Pharmaceuticals (ANIP) | 0.5 | $6.4M | 143k | 45.02 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $68k | 10k | 6.80 |
